BiotechTube
Aucta Pharmaceuticals

Aucta Pharmaceuticals

Piscataway, United States· Est.
auctapharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $35M

Overview

Aucta Pharmaceuticals is a private, US-based specialty pharma company with a dual-site R&D and manufacturing presence in New Jersey and Shanghai. Its strategy centers on using its proprietary AucPed, AucTrol, and AucMist technology platforms to create differentiated dosage forms of established drugs, aiming to improve patient adherence and outcomes. The company is backed by a consortium of global and China-based healthcare investors and is advancing a pipeline focused on CNS and orphan diseases.

Central Nervous System (CNS) DisordersMetabolic DiseasesOrphan and Specialty IndicationsOphthalmicsDermatologyPediatrics

Technology Platform

Aucta's core technology consists of three proprietary platforms: AucPed™ for pediatric formulations, AucTrol™ for controlled-release oral technologies, and AucMist™ for nasal drug delivery, enabling the creation of differentiated dosage forms from proven molecules.

Funding History

4
Total raised:$35M
Series A$12M
Series A$15M
Seed$3M
Seed$5M

Opportunities

The 505(b)(2) pathway offers a large addressable market by improving upon existing drugs in multi-billion dollar therapeutic areas like CNS.
There is significant growth potential in developing pediatric formulations and in leveraging the dual US-China operational model to commercialize products in both major pharmaceutical markets.

Risk Factors

Key risks include regulatory hurdles for 505(b)(2) approvals, commercial competition from originator drugs and generics, execution challenges in managing a dual-country operation, and pipeline dependency on a limited number of lead assets.

Competitive Landscape

Aucta competes with other specialty pharma companies focused on product lifecycle management (e.g., Supernus, Azurity) and generic manufacturers. Its differentiation lies in its proprietary formulation platforms (AucPed, AucTrol, AucMist) and integrated R&D/manufacturing capabilities in both the US and China.

More companies in Drug Delivery & Formulation →More companies in United States →